Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adrenal-Permissive Germline HSD3B1 Allele and Prostate Cancer Outcomes.
McKay RR, Nelson TJ, Pagadala MS, Teerlink CC, Gao A, Bryant AK, Agiri FY, Guram K, Thompson RF, Pridgen KM, Seibert TM, Lee KM, Carter H, Lynch JA, Hauger RL, Rose BS. McKay RR, et al. Among authors: rose bs. JAMA Netw Open. 2024 Mar 4;7(3):e242976. doi: 10.1001/jamanetworkopen.2024.2976. JAMA Netw Open. 2024. PMID: 38506808 Free PMC article.
Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities.
Bryant AK, Lee KM, Alba PR, Murphy JD, Martinez ME, Natarajan L, Green MD, Dess RT, Anglin-Foote TR, Robison B, DuVall SL, Lynch JA, Rose BS. Bryant AK, et al. Among authors: rose bs. JAMA Oncol. 2022 Dec 1;8(12):1747-1755. doi: 10.1001/jamaoncol.2022.4319. JAMA Oncol. 2022. PMID: 36279204 Free PMC article.
Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program.
Pagadala MS, Lynch J, Karunamuni R, Alba PR, Lee KM, Agiri FY, Anglin T, Carter H, Gaziano JM, Jasuja GK, Deka R, Rose BS, Panizzon MS, Hauger RL, Seibert TM. Pagadala MS, et al. Among authors: rose bs. J Natl Cancer Inst. 2023 Feb 8;115(2):190-199. doi: 10.1093/jnci/djac199. J Natl Cancer Inst. 2023. PMID: 36305680 Free PMC article.
Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Loo Gan C, Huang J, Pan E, Xie W, Schmidt AL, Labaki C, Meza L, Bouchard G, Li H, Jackson-Spence F, Sánchez-Ruiz C, Powles T, Kumar SA, Weise N, Hall WA, Rose BS, Beuselinck B, Suarez C, Pal SK, Choueiri TK, Heng DYC, McKay RR. Loo Gan C, et al. Among authors: rose bs. Eur Urol Oncol. 2023 Apr;6(2):204-211. doi: 10.1016/j.euo.2022.10.004. Epub 2022 Nov 1. Eur Urol Oncol. 2023. PMID: 36328934
Response to Haiman, Kote-Jarai, Darst et al.
Seibert TM, Pagadala MS, Lynch J, Karunamuni R, Carter H, Rose BS, Hauger RL. Seibert TM, et al. Among authors: rose bs. J Natl Cancer Inst. 2023 Mar 9;115(3):343-344. doi: 10.1093/jnci/djad006. J Natl Cancer Inst. 2023. PMID: 36629482 Free PMC article. No abstract available.
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial.
Mell LK, Pugh SL, Jones CU, Nelson TJ, Zakeri K, Rose BS, Zeitzer KL, Gore EM, Bahary JP, Souhami L, Michalski JM, Hartford AC, Mishra MV, Roach M 3rd, Parliament MB, Choi KN, Pisansky TM, Husain SM, Malone SC, Horwitz EM, Feng F. Mell LK, et al. Among authors: rose bs. Eur Urol. 2024 Apr;85(4):373-381. doi: 10.1016/j.eururo.2023.01.020. Epub 2023 Jan 28. Eur Urol. 2024. PMID: 36710205
166 results